International Patent: 7-OXO-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE AND 8-OXO-[1,2,4]TRIAZOLO[1,5-A]PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF WERNER SYNDROME RECQ HELICASE (WRN)

GENEVA, Aug. 21 -- JANSSEN PHARMACEUTICA NV filed a patent application (IB2026/051367) for “7-OXO-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE AND 8-OXO-[1,2,4]TRIAZOLO[1,5-A]PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF WERNER SYNDROME RECQ HELICASE (WRN)”. With publication no. WO/2026/172276, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 487/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....